International Urogynecology Journal

, Volume 27, Issue 9, pp 1409–1414 | Cite as

Prevalence of pelvic floor disorders in women with suspected gynecological malignancy: a survey-based study

  • C. Emi BretschneiderEmail author
  • Kemi M. Doll
  • Jeannette T. Bensen
  • Paola A. Gehrig
  • Jennifer M. Wu
  • Elizabeth J. Geller
Original Article


Introduction and hypothesis

Understanding of pelvic floor disorders among women with gynecological cancer is limited. The objective of this study was to describe the prevalence of pelvic floor disorders in women with suspected gynecological malignancy before surgery.


A cross-sectional study was performed of women aged ≥18 with a suspected gynecological malignancy who enrolled in the University of North Carolina Health Registry/Cancer Survivorship Cohort (HR/CSC) from August 2012 to June 2013. Demographics were obtained from the HR/CSC self-reported data; clinical data were abstracted from the electronic medical record. Subjects completed validated questionnaires (Rotterdam Symptom Checklist and the International Consultation on Incontinence Questionnaire-Female Lower Urinary Tract Symptoms) to assess bladder and bowel function.


Among 186 women scheduled for surgery for gynecological malignancy, 152 (82 %) completed baseline assessments before surgery. Mean age was 58.1 ± 13.3 years, and mean BMI was 33.6 ± 8.8 kg/m2. The majority of subjects had uterine cancer (61.8 %), followed by ovarian (17.1 %) and cervical (11.1 %). At baseline, the rate of urinary incontinence (UI) was 40.9 %. A third of subjects reported stress UI, and one quarter reported urge UI. The overall rate of fecal incontinence was 3.9 %, abdominal pain was 47.4 %, constipation was 37.7 %, and diarrhea was 20.1 %. When comparing cancer types, there were no differences in pelvic floor symptoms.


Pelvic floor disorders are common in women with suspected gynecological malignancy at baseline before surgery. Recognizing pelvic floor disorders in the preoperative setting will allow for more individualized, comprehensive care for these women.


Fecal incontinence Gynecological cancer Pelvic floor disorders Urinary incontinence 


Compliance with ethical standards

Conflict of interest

J.M.W. reports personal fees from Proctor and Gamble, outside of the submitted work. The remaining authors report no conflicts of interest.


  1. 1.
    Doll KM, Snavely AC, Kalinowski A, Irwin DE, Bensen JT, Bae-Jump V, Boggess JF, Soper JT, Brewster WR, Gehrig PA (2014) Preoperative quality of life and surgical outcomes in gynecologic oncology patients: a new predictor of operative risk? Gynecol Oncol 133(3):546–551CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Chase DM, Watanabe T, Monk BJ (2010) Assessment and significance of quality of life in women with gynecologic cancer. Future Oncol 6(8):1279–1287CrossRefPubMedGoogle Scholar
  3. 3.
    Penson RT, Wenzel LB, Vergote I, Cella D (2006) Quality of life considerations in gynecologic cancer. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 95 [Suppl 1]:S247–S257Google Scholar
  4. 4.
    Herzog AR, Diokno AC, Brown MB, Fultz NH, Goldstein NE (1994) Urinary incontinence as a risk factor for mortality. J Am Geriatr Soc 42(3):264–268CrossRefPubMedGoogle Scholar
  5. 5.
    DeLancey JO (2005) The hidden epidemic of pelvic floor dysfunction: achievable goals for improved prevention and treatment. Am J Obstet Gynecol 192(5):1488–1495CrossRefPubMedGoogle Scholar
  6. 6.
    Hatchett L, Hebert-Beirne J, Tenfelde S, Lavender MD, Brubaker L (2011) Knowledge and perceptions of pelvic floor disorders among African American and Latina women. Female Pelvic Med Reconstr Surg 17(4):190–194CrossRefPubMedGoogle Scholar
  7. 7.
    Altman D, Falconer C, Cnattingius S, Granath F (2008) Pelvic organ prolapse surgery following hysterectomy on benign indications. Am J Obstet Gynecol 198(5):572.e1–e6CrossRefGoogle Scholar
  8. 8.
    Jackson KS, Naik R (2006) Pelvic floor dysfunction and radical hysterectomy. Int J Gynecol Cancer 16(1):354–363CrossRefPubMedGoogle Scholar
  9. 9.
    Thakar R, Sultan AH (2005) Hysterectomy and pelvic organ dysfunction. Best Pract Res Clin Obstet Gynaecol 19(3):403–418. doi: 10.1016/j.bpobgyn.2005.01.008 CrossRefPubMedGoogle Scholar
  10. 10.
    Brooks RA, Wright JD, Powell MA, Rader JS, Gao F, Mutch DG, Wall LL (2009) Long-term assessment of bladder and bowel dysfunction after radical hysterectomy. Gynecol Oncol 114(1):75–79CrossRefPubMedGoogle Scholar
  11. 11.
    Rutledge TL, Heckman SR, Qualls C, Muller CY, Rogers RG (2010) Pelvic floor disorders and sexual function in gynecologic cancer survivors: a cohort study. Am J Obstet Gynecol 203(5):514.e1–e7CrossRefGoogle Scholar
  12. 12.
    Nosti PA, Sokol AI (2012) Unusual findings on cystoscopy in a patient with detrusor overactivity. Female Pelvic Med Reconstr Surg 18(3):186–187CrossRefGoogle Scholar
  13. 13.
    Jensen PT, Groenvold M, Klee MC, Thranov I, Petersen MA, Machin D (2003) Longitudinal study of sexual function and vaginal changes after radiotherapy for cervical cancer. Int J Radiat Oncol Biol Phys 56(4):937–949CrossRefPubMedGoogle Scholar
  14. 14.
    Hazewinkel MH, Sprangers MA, van der Velden J, van der Vaart CH, Stalpers LJ, Burger MP, Roovers JP (2010) Long-term cervical cancer survivors suffer from pelvic floor symptoms: a cross-sectional matched cohort study. Gynecol Oncol 117(2):281–286CrossRefPubMedGoogle Scholar
  15. 15.
    Thomas SG, Sato HR, Glantz JC, Doyle PJ, Buchsbaum GM (2013) Prevalence of symptomatic pelvic floor disorders among gynecologic oncology patients. Obstet Gynecol 122(5):976–980CrossRefPubMedGoogle Scholar
  16. 16.
    De Haes JC, van Knippenberg FC, Neijt JP (1990) Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer 62(6):1034–1038Google Scholar
  17. 17.
    Brookes ST, Donovan JL, Wright M, Jackson S, Abrams P (2004) A scored form of the Bristol Female Lower Urinary Tract Symptoms questionnaire: data from a randomized controlled trial of surgery for women with stress incontinence. Am J Obstet Gynecol 191(1):73–82CrossRefPubMedGoogle Scholar
  18. 18.
    Nitti VW (2001) The prevalence of urinary incontinence. Rev Urol 3 [Suppl 1]:S2PubMedPubMedCentralGoogle Scholar
  19. 19.
    Wu JM, Vaughan CP, Goode PS, Redden DT, Burgio KL, Richter HE, Markland AD (2014) Prevalence and trends of symptomatic pelvic floor disorders in U.S. women. Obstet Gynecol 123(1):141–148CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Lawrence JM, Lukacz ES, Nager CW, Hsu JW, Luber KM (2008) Prevalence and co-occurrence of pelvic floor disorders in community-dwelling women. Obstet Gynecol 111(3):678–685CrossRefPubMedGoogle Scholar
  21. 21.
    Del Priore G, Taylor SY, Esdaile BA, Masch R, Martas Y, Wirth J (2005) Urinary incontinence in gynecological oncology patients. Int J Gynecol Cancer 15(5):911–914CrossRefPubMedGoogle Scholar

Copyright information

© The International Urogynecological Association 2016

Authors and Affiliations

  • C. Emi Bretschneider
    • 1
  • Kemi M. Doll
    • 2
  • Jeannette T. Bensen
    • 3
  • Paola A. Gehrig
    • 2
  • Jennifer M. Wu
    • 1
    • 4
  • Elizabeth J. Geller
    • 1
  1. 1.Division of Urogynecology, Department of Obstetrics and GynecologyUniversity of North Carolina at Chapel HillChapel HillUSA
  2. 2.Division of Gynecologic Oncology, Department of Obstetrics and GynecologyUniversity of North Carolina at Chapel HillChapel HillUSA
  3. 3.Department of EpidemiologyUniversity of North Carolina at Chapel HillChapel HillUSA
  4. 4.Center for Women’s Health ResearchUniversity of North Carolina at Chapel HillChapel HillUSA

Personalised recommendations